title: Possible prognostic role of IL-17R in osteosarcoma.
abstract: OBJECTIVE
  An intense vascularization of primary tumor mass is associated with a fatal outcome in various types of invasive solid tumors. Interleukin 17 (IL-17), a CD4+ T-cell-derived cytokine, stimulates some tumor cells to secrete angiogenic factors, among which venous endothelial growth factor (VEGF). We assessed whether the expression of IL-17 receptor (IL-17R) represents a marker for the metastasizing ability of osteosarcoma (OS), a very malignant bone tumor.
  
  
  METHODS
  We immunoassayed the amount of VEGF secreted by three OS cell lines expressing IL-17R in differing amounts: HOS, MG63 and U-2 OS, and their sensitivity to IL-17 stimulation to secrete VEGF.
  
  
  RESULTS
  U-2 OS, which best expresses IL-17R, secreted the highest amounts of VEGF and was the most sensitive to IL-17, whereas MG63 expressed the lowest level of IL-17R, secreted the lowest amount of VEGF and was not sensitive to IL-17. IL-17R expression correlated with VEGF secretion and IL-17 sensitivity. U-2 OS expressed the most dedifferentiated phenotype, which is associated with tumor malignancy.
  
  
  CONCLUSIONS
  These results suggest that IL-17R in OS might represent a marker of tumor metastasis potential.
authors: Dipartimento di Medicina Interna e Gastroenterologia, Università di Bologna, Via Massarenti 9, 40136 Bologna, Italy. labimge@alma.unibo.it
authors: Maria Cristina
authors: MC
authors: Honorati
authors: Luca
authors: L
authors: Cattini
authors: Andrea
authors: A
authors: Facchini
mesh_terms: D014408:Biomarkers, Tumor / Q000032:analysis; D001859:Bone Neoplasms / Q000378:metabolism* / Q000473:pathology*; D045744:Cell Line, Tumor; D006801:Humans; D009362:Neoplasm Metastasis; D012516:Osteosarcoma / Q000378:metabolism* / Q000473:pathology*; D011379:Prognosis; D053722:Receptors, Interleukin-17 / Q000378:metabolism*; D042442:Vascular Endothelial Growth Factors / Q000378:metabolism
chemical_list: D014408:Biomarkers, Tumor; D053722:Receptors, Interleukin-17; D042442:Vascular Endothelial Growth Factors
references: Br J Cancer. 2002 May 20;86(10):1566-77
references: 12085206
references: J Bone Miner Res. 1996 Apr;11(4):512-20
references: 8992882
references: Cell. 1996 Aug 9;86(3):353-64
references: 8756718
references: Pediatr Hematol Oncol. 2004 Oct-Nov;21(7):611-9
references: 15626017
references: Clin Exp Immunol. 2003 Sep;133(3):344-9
references: 12930359
references: Mod Pathol. 2006 May;19(5):738-45
references: 16528367
references: J Natl Cancer Inst. 2006 Mar 1;98(5):316-25
references: 16507828
references: J Immunol. 2005 Nov 1;175(9):6177-89
references: 16237115
references: Cancer. 2007 Mar 1;109(5):813-9
references: 17265525
references: Clin Cancer Res. 2000 Feb;6(2):572-7
references: 10690541
references: Cell. 2000 Jan 7;100(1):57-70
references: 10647931
references: Semin Cell Dev Biol. 2005 Aug-Oct;16(4-5):554-63
references: 16144692
references: Osteoarthritis Cartilage. 2006 Apr;14(4):345-52
references: 16311048
references: Mol Divers. 2006 Nov;10(4):515-27
references: 16972015
references: Anticancer Res. 2003 May-Jun;23(3A):1969-96
references: 12894571
references: Cancer Res. 1999 Dec 1;59(23):6010-4
references: 10606250
references: Blood. 2003 Apr 1;101(7):2620-7
references: 12411307
references: Osteoarthritis Cartilage. 2004 Sep;12(9):683-91
references: 15325633
references: J Egypt Natl Canc Inst. 2004 Mar;16(1):57-61
references: 15716999
references: Bone. 1994 Nov-Dec;15(6):585-91
references: 7873286
references: Nature. 2004 Feb 26;427(6977):787
references: 14985739
references: J Bone Miner Res. 2000 Jul;15(7):1257-65
references: 10893674
references: Biochem Biophys Res Commun. 2001 Apr 6;282(3):735-8
references: 11401524
references: Cancer. 2006 Jun 15;106(12):2682-91
references: 16691621
references: Oncol Rep. 2006 Jul;16(1):17-23
references: 16786118
references: Eur J Intern Med. 2006 Oct;17(6):412-6
references: 16962948
references: Ann Surg. 2003 Jul;238(1):9-28
references: 12832961
references: FASEB J. 2002 Sep;16(11):1361-70
references: 12205027
references: Int J Oncol. 1993 Nov;3(5):963-9
references: 21573460
references: Int Semin Surg Oncol. 2006 Mar 21;3:7
references: 16551370